Appili Therapeutics Announces Results of Annual and Special Meeting of Shareholders
Based on the proxies received and the vote conducted at the meeting, all tabled resolutions were approved by the shareholders of the Company, including the election of the following directors for the ensuing year:
Voting results for each director are summarized below:
Percentage of Votes For | Percentage of Votes Against | Percentage of Votes Withheld | |
19,490,794 (98.42%) | 307,825 (1.55%) | 5,300 (0.03%) | |
16,812,009 (84.89%) | 2,985,610 (15.08%) | 6,300 (0.03%) | |
16,808,009 (84.87%) | 2,989,610 (15.10%) | 6,300 (0.03%) | |
19,489,794 (98.41%) | 307,825 (1.55%) | 6,300 (0.03%) | |
19,490,794 (98.42%) | 307,825 (1.55%) | 5,300 (0.03%) | |
16,808,009 (84.87%) | 2,989,610 (15.10%) | 6,300 (0.03%) |
In addition to the election of the directors of the Company as noted above, the Shareholders:
- re-appointed
PricewaterhouseCoopers, LLP , Chartered Accountants, as the independent auditor of the Company for the ensuing year and authorized the directors of the Company to fix their remuneration; - approved amendments to the Company’s stock option plan to, inter alia, change the plan from a “fixed plan” to a rolling 10% plan; and
- approved the Company’s equity incentive plan.
The Company has filed a report of the voting results on all resolutions voted on the Meeting on the Company’s SEDAR profile at www.sedar.com
About
View source version on businesswire.com: https://www.businesswire.com/news/home/20220922005885/en/
Media Contact:
T: 1-646-717-9915
E: DRaabe@apcoworldwide.com
Investor Relations Contact:
Info@AppiliTherapeutics.com
Source: